Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115536720B reveals plant-based cholic acid intermediate synthesis. Eliminates animal extraction risks. Offers scalable pharmaceutical intermediates manufacturing solutions.
Patent CN107032971B reveals a mild acid-catalyzed route for 3,7-dimethyl-6-carbonyl-2-octenal, offering significant cost reduction and simplified supply chain operations for fine chemical manufacturing.
Patent CN111072540A details a novel DMSO-mediated ring-opening and Diels-Alder purification strategy for high-purity alfacalcidol, offering significant cost reduction in API manufacturing.
Patent CN114394892B reveals a high-purity synthesis route for R-3-hydroxybutyrate. This method ensures supply chain stability and significant cost reduction.
Novel Grignard-based route for Photoinitiator 184 ensures high yield and reduced waste. Ideal for reliable coating chemical supply chains seeking cost efficiency.
Patent CN102964221B details a waste-free diazotization route for 2,5-dichlorophenol, offering significant cost reduction and supply chain reliability for herbicide manufacturing.
Patent CN112094274A reveals a safer tofacitinib synthesis eliminating high-pressure hydrogen risks while controlling formylated impurities through precise alkaline hydrolysis.
Advanced hydrolysis method for 3-(3-phenylsulfamoyl-phenyl)-acrylic acid. High-yield process for Belinostat intermediates ensuring supply chain stability.
Patent CN107098936B reveals a novel crown ether-catalyzed hydrolysis for TAF intermediates, offering superior purity and supply chain reliability for pharmaceutical manufacturers.
Novel synthesis of TDF impurities ensures high-purity API manufacturing. Reliable supplier for pharmaceutical intermediates offering cost reduction and supply continuity.
Patent CN101190927A reveals a streamlined synthesis for Adefovir Monoester via selective hydrolysis, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Advanced patent CN102060876A details a safer, cost-effective route for high-purity tenofovir intermediates, eliminating hazardous reagents for scalable API manufacturing.
Patent CN105461606A reveals enzymatic hydrolysis for Ledipasvir intermediates. Achieve >99% de purity and scalable green manufacturing for Hepatitis C drug supply chains.
Advanced synthesis of synthetic cannabinoid haptens via mild alkylation and peptide coupling. Offers high-purity intermediates for immunoassay development and cost-effective manufacturing.
Discover the patented CN102146022A method for 3-chloro-5-bromophenol. Achieve high purity and cost reduction in fine chemical manufacturing with our scalable route.
Advanced process for D-tyrosine production using tartrate resolution. Offers superior cost efficiency and scalability for pharmaceutical intermediate manufacturing compared to enzymatic methods.
Patent CN110759957B reveals a novel KOH-catalyzed route for lipid-soluble isoguanosine intermediates, enhancing bioavailability and reducing purification costs for antisense therapies.
Novel synthesis route for pharmaceutical intermediate CAS 887707-23-5 ensures high yield and supply chain stability for global procurement teams.
Patent CN1115343C details a novel enzymatic route for chiral cyclopentene amines, offering cost-effective API intermediate manufacturing with high enantiomeric purity.
Patent CN107098936A reveals mild catalytic route for TAF intermediates ensuring high purity and supply chain stability for global pharmaceutical manufacturing partners.